Xtant Medical Holdings, Inc. (XTNT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 50M 100M 150M FY10: 15.4M FY11: 30.1M FY12: 33M FY13: 33.1M FY14: 35.3M FY15: 59.3M FY16: 90M FY17: 82.6M FY18: 72.2M FY19: 64.7M FY20: 53.3M FY21: 55.3M FY22: 58M FY23: 91.3M FY24: 117.3M FY25: 133.9M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 30M 60M 90M FY10: 12.1M FY11: 21M FY12: 22.6M FY13: 18.9M FY14: 22.3M FY15: 39.1M FY16: 62.3M FY17: 50.1M FY18: 43.5M FY19: 42.5M FY20: 34.4M FY21: 32.5M FY22: 32.1M FY23: 55.5M FY24: 68.2M FY25: 84.3M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-75M -50M -25M 0 25M 50M 75M FY10: -8.6M FY11: -6.5M FY12: -4.9M FY13: -9M FY14: -6.3M FY15: -12.1M FY16: -7.5M FY17: -37.8M FY18: -60.1M FY19: -2.3M FY20: -751K FY21: -3.9M FY22: -6.8M FY23: -10.2M FY24: -12.1M FY25: 7.3M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-75M -50M -25M 0 25M 50M 75M FY10: -19.5M FY11: -3M FY12: -7.7M FY13: -12.7M FY14: -10.5M FY15: -2.2M FY16: -19.5M FY17: -52.4M FY18: -70.1M FY19: -8.2M FY20: -7M FY21: -4.8M FY22: -8.5M FY23: 660K FY24: -16.4M FY25: 5M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 20M 40M 60M FY11: 9.1M FY12: 10.3M FY13: 14.2M FY14: 13M FY15: 20.3M FY16: 27.7M FY17: 32.5M FY18: 28.7M FY19: 22.2M FY20: 18.9M FY21: 22.8M FY22: 25.8M FY23: 35.8M FY24: 49.1M FY25: 49.7M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

-15M -10M -5M 0 5M 10M 15M FY10: -8.4M FY11: -7.4M FY12: -10.8M FY13: -4.9M FY14: -7.3M FY15: -9.1M FY16: -14.4M FY17: -543K FY18: 1.2M FY19: -413K FY20: -731K FY21: 439K FY22: -5.3M FY23: -9.5M FY24: -11.9M FY25: 12.5M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-21M -14M -7M 0 7M 14M 21M FY10: -9.2M FY11: -8.3M FY12: -12.6M FY13: -5.5M FY14: -7.6M FY15: -11.4M FY16: -20.2M FY17: -2.2M FY18: 588K FY19: -1.3M FY20: -2.3M FY21: -1.7M FY22: -7.1M FY23: -11M FY24: -16M FY25: 10.2M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 60M 120M 180M FY10: 32.2M FY11: 38.9M FY12: 42.4M FY13: 4.5M FY14: 6M FY15: 9.1M FY16: 1.1M FY17: 1.5M FY18: 11.7M FY19: 13.2M FY20: 28.5M FY21: 85.5M FY22: 94.1M FY23: 126.8M FY24: 133.7M FY25: 150M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-45.00 -30.00 -15.00 0.00 15.00 30.00 45.00 Q4 '10: -0.61 Q1 '11: -0.41 Q2 '11: -0.35 Q1 '13: -0.19 Q2 '13: -0.76 Q3 '13: -1.55 Q4 '13: -2.41 Q1 '14: -3.14 Q2 '14: -2.94 Q3 '14: -2.28 Q4 '14: -1.81 Q1 '15: -1.66 Q2 '15: -1.72 Q3 '15: -2.17 Q4 '15: -0.24 Q1 '16: -0.09 Q2 '16: -0.05 Q3 '16: 0.19 Q4 '16: -18.46 Q1 '17: -21.86 Q2 '17: -27.92 Q3 '17: -33.14 Q4 '17: -34.74 Q1 '18: -31.57 Q2 '18: -25.52 Q3 '18: -20.14 Q4 '18: -6.10 Q1 '19: -5.61 Q2 '19: -5.38 Q3 '19: -5.28 Q4 '19: -0.63 Q1 '20: -0.61 Q2 '20: -0.65 Q3 '20: -0.61 Q4 '20: -0.25 Q1 '21: -0.06 Q2 '21: 0.12 Q3 '21: 0.20 Q4 '21: -0.06 Q1 '22: -0.09 Q2 '22: -0.10 Q3 '22: -0.11 Q4 '22: -0.10 Q1 '23: -0.09 Q2 '23: -0.09 Q3 '23: 0.01 Q4 '23: 0.01 Q1 '24: 0.00 Q2 '24: -0.01 Q3 '24: -0.12 Q4 '24: -0.12 Q1 '25: -0.09 Q2 '25: -0.04 Q3 '25: 0.01 Q4 '25: 0.03 Q1 '26: 0.01 Q2 '26: -0.08 Q4 '10 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.